River Wealth Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-21,343
Closed -$1.84M 206
2024
Q4
$1.84M Sell
21,343
-13,645
-39% -$1.48M 0.24% 85
2024
Q3
$4.17M Buy
34,988
+5,365
+18% +$715K 0.56% 49
2024
Q2
$4.23M Buy
29,623
+13,786
+87% +$1.83M 0.61% 45
2024
Q1
$2.03M Buy
+15,837
New +$1.89M 0.3% 83

Other funds holding NVO

River Wealth Advisors's NVO Position: Q1 2025 in Review

River Wealth Advisors sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 21,343 shares — an estimated $1.84M sold.

River Wealth Advisors first reported a position in NVO in Q1 2024 and held it in 4 quarters. The position peaked at $4.23M in Q2 2024. 1,529 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • River Wealth Advisors reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • River Wealth Advisors sold 21,343 Novo Nordisk shares in Q1 2025, an estimated $1.84M.
  • River Wealth Advisors first reported a position in Novo Nordisk in Q1 2024 and held it in 4 quarters.
  • River Wealth Advisors's Novo Nordisk position peaked at $4.23M in Q2 2024.
  • 1,529 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on River Wealth Advisors's 13F filing for Q1 2025, filed 14 May 2025.